JP2023511898A5 - - Google Patents
Info
- Publication number
- JP2023511898A5 JP2023511898A5 JP2022544267A JP2022544267A JP2023511898A5 JP 2023511898 A5 JP2023511898 A5 JP 2023511898A5 JP 2022544267 A JP2022544267 A JP 2022544267A JP 2022544267 A JP2022544267 A JP 2022544267A JP 2023511898 A5 JP2023511898 A5 JP 2023511898A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- bispecific antibody
- binding moiety
- seq
- binding portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020073497 | 2020-01-21 | ||
| CNPCT/CN2020/073497 | 2020-01-21 | ||
| PCT/CN2021/072584 WO2021147829A1 (en) | 2020-01-21 | 2021-01-19 | A bispecific anti-pd-l1/vegf antibody and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023511898A JP2023511898A (ja) | 2023-03-23 |
| JP2023511898A5 true JP2023511898A5 (https=) | 2024-01-09 |
| JP7692422B2 JP7692422B2 (ja) | 2025-06-13 |
Family
ID=76993149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544267A Active JP7692422B2 (ja) | 2020-01-21 | 2021-01-19 | 二重特異性抗ｐｄ－ｌ１／ｖｅｇｆ抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230242645A1 (https=) |
| EP (1) | EP4093765A4 (https=) |
| JP (1) | JP7692422B2 (https=) |
| AU (1) | AU2021210025A1 (https=) |
| BR (1) | BR112022014487A2 (https=) |
| CA (1) | CA3165556A1 (https=) |
| WO (1) | WO2021147829A1 (https=) |
| ZA (1) | ZA202208337B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114106190B (zh) * | 2020-08-31 | 2025-04-08 | 普米斯生物技术(珠海)有限公司 | 一种抗vegf/pd-l1双特异性抗体及其用途 |
| CN114230669B (zh) * | 2021-12-24 | 2024-01-30 | 天士力生物医药股份有限公司 | 一种双特异性抗体的生产方法 |
| EP4543488A2 (en) * | 2022-08-25 | 2025-04-30 | Bright Biologics LLC | Multispecific antibodies and uses thereof |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| WO2025257394A1 (en) * | 2024-06-14 | 2025-12-18 | BioNTech SE | Combination therapy for cancer treatment |
| WO2025256761A1 (en) * | 2024-06-14 | 2025-12-18 | BioNTech SE | Combination therapy for cancer treatment |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6884879B1 (en) * | 1997-04-07 | 2005-04-26 | Genentech, Inc. | Anti-VEGF antibodies |
| CN106397592A (zh) * | 2015-07-31 | 2017-02-15 | 苏州康宁杰瑞生物科技有限公司 | 针对程序性死亡配体(pd-l1)的单域抗体及其衍生蛋白 |
| CN109575140B (zh) * | 2017-09-29 | 2021-02-23 | 北京比洋生物技术有限公司 | 靶向pd-1或pd-l1且靶向vegf家族的双靶向融合蛋白及其用途 |
| CA3090878A1 (en) * | 2018-02-11 | 2019-08-15 | Beijing Hanmi Pharmaceutical Co., Ltd. | Anti-pd-1/anti-vegf natural antibody structure-like heterodimeric form bispecific antibody and preparation thereof |
| EP3758735B1 (en) * | 2018-02-28 | 2023-12-13 | AP Biosciences, Inc. | Bifunctional proteins combining checkpoint blockade for targeted therapy |
| CN110305210B (zh) * | 2018-03-27 | 2023-02-28 | 信达生物制药(苏州)有限公司 | 新型抗体分子、其制备方法及其用途 |
| WO2019184909A1 (zh) * | 2018-03-27 | 2019-10-03 | 信达生物制药(苏州)有限公司 | 新型抗体分子、其制备方法及其用途 |
| CN109053895B (zh) | 2018-08-30 | 2020-06-09 | 中山康方生物医药有限公司 | 抗pd-1-抗vegfa的双功能抗体、其药物组合物及其用途 |
| CN109942712B (zh) * | 2019-04-01 | 2022-12-20 | 华博生物医药技术（上海）有限公司 | 抗pd-l1/vegf双功能抗体及其用途 |
| WO2021057836A1 (en) | 2019-09-25 | 2021-04-01 | Wuxi Biologics (Shanghai) Co. Ltd. | Novel anti-pd-l1 antibodies |
-
2021
- 2021-01-19 EP EP21744356.3A patent/EP4093765A4/en active Pending
- 2021-01-19 WO PCT/CN2021/072584 patent/WO2021147829A1/en not_active Ceased
- 2021-01-19 AU AU2021210025A patent/AU2021210025A1/en active Pending
- 2021-01-19 JP JP2022544267A patent/JP7692422B2/ja active Active
- 2021-01-19 BR BR112022014487A patent/BR112022014487A2/pt unknown
- 2021-01-19 CA CA3165556A patent/CA3165556A1/en active Pending
- 2021-01-19 US US17/792,386 patent/US20230242645A1/en active Pending
-
2022
- 2022-07-26 ZA ZA2022/08337A patent/ZA202208337B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023511898A5 (https=) | ||
| CN107614529B (zh) | Pd-l1抗体、其抗原结合片段及其医药用途 | |
| JP2022512653A5 (https=) | ||
| JP2021098733A5 (https=) | ||
| WO2022105832A1 (zh) | 抗pd-l1纳米抗体及三功能融合蛋白 | |
| JP2012501670A5 (https=) | ||
| RU2019128134A (ru) | Антитело против gprc5d и молекула, содержащая антитело | |
| JP2020533311A5 (ja) | ＮＫＧ２Ｄ、ＣＤ１６およびＮｅｃｔｉｎ４に結合するタンパク質 | |
| JP2023551027A5 (https=) | ||
| JP2019527553A5 (https=) | ||
| JP2020525032A5 (https=) | ||
| JP2020510422A5 (https=) | ||
| JP2020508997A5 (https=) | ||
| FI3582806T3 (fi) | Her2:ta, nkg2d:tä ja cd16:ta sitovia proteiineja | |
| JP2018510636A5 (https=) | ||
| JP2022521705A5 (https=) | ||
| JP2021521793A5 (https=) | ||
| JP2024530451A (ja) | 抗ｐｖｒｉｇ／抗ｔｉｇｉｔ二重特異性抗体及び応用 | |
| JP7821159B2 (ja) | Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子 | |
| JP2023543493A5 (https=) | ||
| JP2020534012A5 (https=) | ||
| JP2023549851A5 (https=) | ||
| JP2023548529A5 (https=) | ||
| JP7418326B2 (ja) | 二重特異性抗体並びにその製造方法及び使用方法 | |
| CN115461373A (zh) | 密蛋白18.2的抗体及其用途 |